| __timestamp | HUTCHMED (China) Limited | Ionis Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 72049000 | 241751000 |
| Thursday, January 1, 2015 | 110777000 | 322292000 |
| Friday, January 1, 2016 | 156328000 | 344320000 |
| Sunday, January 1, 2017 | 175820000 | 374644000 |
| Monday, January 1, 2018 | 143944000 | 1820000 |
| Tuesday, January 1, 2019 | 160152000 | 4000000 |
| Wednesday, January 1, 2020 | 188519000 | 12000000 |
| Friday, January 1, 2021 | 258234000 | 11000000 |
| Saturday, January 1, 2022 | 311103000 | 14000000 |
| Sunday, January 1, 2023 | 384447000 | 9133000 |
Igniting the spark of knowledge
In the ever-evolving pharmaceutical landscape, understanding cost dynamics is crucial. From 2014 to 2023, HUTCHMED (China) Limited and Ionis Pharmaceuticals, Inc. have shown contrasting trends in their cost of revenue. HUTCHMED's cost of revenue surged by over 430%, peaking in 2023, reflecting its aggressive expansion and increased production capabilities. In contrast, Ionis Pharmaceuticals experienced a dramatic decline of approximately 96% from its 2017 peak, indicating a strategic shift or operational efficiencies.
These trends highlight the diverse strategies employed by pharmaceutical giants in navigating market challenges and opportunities.
Comparing Cost of Revenue Efficiency: Eli Lilly and Company vs Ionis Pharmaceuticals, Inc.
Cost of Revenue Trends: Neurocrine Biosciences, Inc. vs HUTCHMED (China) Limited
Comparing Cost of Revenue Efficiency: Incyte Corporation vs Ionis Pharmaceuticals, Inc.
Analyzing Cost of Revenue: Dr. Reddy's Laboratories Limited and Ionis Pharmaceuticals, Inc.
Cost of Revenue Comparison: Sarepta Therapeutics, Inc. vs HUTCHMED (China) Limited
Cost of Revenue Trends: Pharming Group N.V. vs HUTCHMED (China) Limited
Cost Insights: Breaking Down Telix Pharmaceuticals Limited and Ionis Pharmaceuticals, Inc.'s Expenses
Cost of Revenue Trends: Ionis Pharmaceuticals, Inc. vs CRISPR Therapeutics AG
Cost of Revenue Trends: Ionis Pharmaceuticals, Inc. vs PTC Therapeutics, Inc.
Cost of Revenue Trends: ACADIA Pharmaceuticals Inc. vs HUTCHMED (China) Limited
Cost of Revenue Comparison: HUTCHMED (China) Limited vs Wave Life Sciences Ltd.
Comparing Cost of Revenue Efficiency: HUTCHMED (China) Limited vs Travere Therapeutics, Inc.